Replies to post #96215 on Ayala Pharmaceuticals Inc (ADXS)

[$5.95akadawson-m]

ADXS made it into the Wall Street Journal on March 29 with a really great headline:

https://www.wsj.com/articles/PR-CO-20190329-913338

Preliminary Data from Phase 1 Study Evaluating ADXS-NEO Suggest Rapid Immunogenicity and Clinical Activity